Aptose Biosciencesincis A Clinical Stage Biotechnology Company Based In Torontoontariocanadathe Company Focuses On Developing Innovative Therapies For Oncologyparticularly Targeting Hematologic Malignanciesoriginally Incorporated As Lorus Therapeutics Incin 1986It Rebranded To Aptose Biosciences In 2014 The Company Is Dedicated To Advancing New Therapeutics That Target Both Well Validated And Novel Drug Targets In Cancer Researchits Pipeline Includes Small Molecules Aimed At Providing Potent Single Agent Activity And Enhancing The Efficacy Of Existing Anti Cancer Therapiesaptose Emphasizes Collaborative Partnerships With Academic Institutions And Industry Partners To Drive Its Research And Development Effortsthe Management Team Consists Of Experienced Professionals From The Biotechnology And Pharmaceutical Sectorscontributing To The Company S Mission Of Making A Meaningful Impact On Patient Care
